Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Receptor BioLogix

Receptor BioLogix, Inc. is a biopharmaceutical company focused on developing the first broad-spectrum anti-HER therapeutic, resulting from its program to commercialize a newly discovered class of protein therapeutics called Intron Fusion Proteins™ (IFP™) to treat cancer, autoimmune, metabolic and other diseases.


Contact Details:
1140 Veterans Boulevard, Suite A
South San Francisco,
California
94080
United States of America
Tel:(650) 266-4600
Fax:(650) 952-2205
Email:info@rblx.com
WWW:

www.rblx.com/




Loading...

Recent Publications by Receptor BioLogix:

Rational optimization of a bispecific ligand trap targeting EGF receptor family ligands.
The human epidermal growth factor (EGF) receptor (HER) family members...
10th February, 2009
Receptor BioLogix Inc., Palo Alto, California, United States of America. Mol Med. 2009 Jan-Feb;15(1-2):11-20. Epub 2008 Nov 17.
DOI Direct Link
Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis.
INTRODUCTION: Despite the advent of biological therapies for the treatment...
7th February, 2009
Receptor BioLogix, Arthritis Res Ther. 2008;10(4):R73. Epub 2008 Jul 1.
DOI Direct Link
A pan-HER approach for cancer therapy: background, current status and future development.
BACKGROUND: The human EGF receptor (EGFR or HER) family and its cognate...
14th January, 2009
Receptor BioLogix, Inc., Palo Alto, CA 94303, USA. Expert Opin Biol Ther. 2009 Jan;9(1):97-110.
DOI Direct Link
Signal integration: a framework for understanding the efficacy of therapeutics targeting the human EGFR family.
The human EGFR (HER) family is essential for communication between many...
13th January, 2009
Receptor BioLogix, Inc., J Clin Invest. 2008 Nov;118(11):3574-81.
DOI Direct Link
Human epidermal growth factor receptor (HER-1:HER-3) Fc-mediated heterodimer has broad antiproliferative activity in vitro and in human tumor xenografts.
All four members of the human epidermal growth factor (EGF) receptor (HER)...
13th November, 2008
Receptor BioLogix, Inc., 3350 West Bayshore Road, Suite 150, Palo Alto, CA Mol Cancer Ther. 2008 Oct;7(10):3223-36.
DOI Direct Link

View more Receptor BioLogix research publications.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 474 times since April 2007, the link to the organisation's website has been followed 92 times

Recent Search Terms used to find this page: RBLX Therapeutics | BIO-LOGIX | receptor biologix | .

Search for more companies in South San Francisco,

Search for more companies in California



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Receptor BioLogix

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.